Continuing Trending of Monkeypox and Covid
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to
Key Points: COVID In today’s Recommendation for Industry, we discuss flu season in the Southern Hemisphere. Read more below. Serious adverse events rare after COVID-19
TAG Expands Assessments to Include Current Communicable Disease Data Key Points: COVID In today’s Recommendation for Industry, we discuss TAG expanding our public health offerings
Key Points: In today’s Recommendation for Industry, we discuss the “why” behind testing at Day 6 if you’ve been exposed and testing multiple times for
Key Points: In today’s Recommendation for Industry, we discuss the positive COVID trends we are seeing. Read more below. Study: Pfizer COVID vaccine efficacy wanes
Key Points: In today’s Recommendation for Industry, we discuss the ongoing monkeypox headlines. Read more below. US COVID cases show hints of decline. The 7-day
Key Points: In today’s Recommendation for Industry, we discuss CDC’s reduction in COVID guidelines. Read more below. New York Times reports updates about COVID: Hospitalizations
Key Points: In today’s Recommendation for Industry, we discuss if there is a risk of monkeypox transmission within the workplace. Read more below. Moderna announces
Key Points: In today’s Recommendation for Industry, we discuss COVID becoming an endemic virus. Read more below. COVID hot spots shift; studies add evidence for
Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines.